The Feng Yang lab's research involves the investigation of the molecular mechanisms underlying therapy-resistance of human cancers, tumor microenvironment - prostate cancer interaction, and developing novel transgenic model for human prostate cancer. Postdoc positions are open.
The lab is currently funded by the Department of Defense Prostate Cancer Research Program, National Institute of Health / National Cancer Institute, and the Cancer Prevention & Research Institute of Texas.
Our lab is involved with the following projects. Read more about each on our projects webpage.
- MAPK4 biology in regulating key signaling pathways in human cancers
- Tumor microenvironment regulation of prostate cancer
- Development of a novel transgenic model for prostate cancer
- FGFR1 signaling in prostate cancer and breast cancer